Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of lasmiditan in Japan
jRCT2080225222Phase 3Recruiting
- Start
- Jun 2020
- Modality
- Small Molecules
01
Overview
Phase 3 trial of lasmiditan in migraine. Started Jun 2020; status: recruiting.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on jRCT2080225222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225222.